| 2.14 0.015 (0.71%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.92 | 1-year : | 3.46 |
| Resists | First : | 2.5 | Second : | 2.96 |
| Pivot price | 2.25  |
|||
| Supports | First : | 1.75 | Second : | 1.45 |
| MAs | MA(5) : | 2.23 |
MA(20) : | 2.31 |
| MA(100) : | 1.79 |
MA(250) : | 1.6 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 34.3 |
D(3) : | 38.4 |
| RSI | RSI(14): 48.1  |
|||
| 52-week | High : | 3.46 | Low : | 0.33 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MRAI ] has closed above bottom band by 26.1%. Bollinger Bands are 48.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.24 - 2.25 | 2.25 - 2.26 |
| Low: | 2.06 - 2.08 | 2.08 - 2.09 |
| Close: | 2.12 - 2.14 | 2.14 - 2.16 |
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
Wed, 24 Apr 2024
MARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES - Yahoo Finance Australia
Tue, 16 Apr 2024
MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES - PR Newswire
Sun, 07 Apr 2024
Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30% - Simply Wall St
Thu, 28 Mar 2024
Marpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call Transcript - Yahoo Finance
Wed, 13 Mar 2024
NASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING ... - PR Newswire
Wed, 06 Mar 2024
MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 10 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 61 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 201 (K) |
| Shares Short P.Month | 41 (K) |
| EPS | -4.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.7 |
| Profit Margin | -77.4 % |
| Operating Margin | -44.9 % |
| Return on Assets (ttm) | -40.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 14.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.6 |
| EBITDA (p.s.) | -2.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -16 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.52 |
| PEG Ratio | 0 |
| Price to Book value | -1.27 |
| Price to Sales | 0.59 |
| Price to Cash Flow | -1.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|